These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 7987264

  • 1. Inhibition of ADP-induced human platelet aggregation by a new class of soluble guanylate cyclase activators capable of nitric oxide generation.
    Severina IS, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1994 Aug; 33(5):957-67. PubMed ID: 7987264
    [Abstract] [Full Text] [Related]

  • 2. [Inhibition of human platelet aggregation by a new class of soluble guanylate cyclase inhibitor, generating nitric oxide].
    Belushkina NN, Grigor'ev NB, Severina IS.
    Biokhimiia; 1994 Nov; 59(11):1689-97. PubMed ID: 7873676
    [Abstract] [Full Text] [Related]

  • 3. [A new class of soluble guanylate cyclase activators, generating nitric oxide].
    Riaposova IK, Grigor'ev NV, Severina IS.
    Biokhimiia; 1994 Apr; 59(4):537-42. PubMed ID: 7912551
    [Abstract] [Full Text] [Related]

  • 4. Derivatives of 1,2-diazetidine-1,2-di-N-oxides--a new class of soluble guanylate cyclase activators with vasodilatory properties.
    Severina IS, Ryaposova IK, Volodarsky LB, Mozhuchin DC, Tichonov AYa, Schwartz GYa, Granik VG, Grigoryev DA, Grigoryev NB.
    Biochem Mol Biol Int; 1993 Jun; 30(2):357-66. PubMed ID: 8103389
    [Abstract] [Full Text] [Related]

  • 5. [A new activator of soluble guanylate cyclase generated by nitric oxide and having antihypertensive and anti-aggregation properties].
    Busygina OG, Belushkina NN, Grigor'ev NB, Severina IS.
    Biokhimiia; 1995 Sep; 60(9):1460-7. PubMed ID: 8562654
    [Abstract] [Full Text] [Related]

  • 6. Guanidine thiol--a new activator of soluble guanylate cyclase with antihypertensive and antiaggregatory properties.
    Severina IS, Bussygina OG, Belushkina NN, Grigoryev NB.
    Biochem Mol Biol Int; 1995 Jul; 36(4):913-25. PubMed ID: 8528155
    [Abstract] [Full Text] [Related]

  • 7. Inhibition of human platelet aggregation by S-nitrosothiols. Heme-dependent activation of soluble guanylate cyclase and stimulation of cyclic GMP accumulation.
    Mellion BT, Ignarro LJ, Myers CB, Ohlstein EH, Ballot BA, Hyman AL, Kadowitz PJ.
    Mol Pharmacol; 1983 May; 23(3):653-64. PubMed ID: 6135148
    [Abstract] [Full Text] [Related]

  • 8. Role of soluble guanylate cyclase in the molecular mechanism underlying the physiological effects of nitric oxide.
    Severina IS.
    Biochemistry (Mosc); 1998 Jul; 63(7):794-801. PubMed ID: 9721331
    [Abstract] [Full Text] [Related]

  • 9. [Soluble platelet guanylate cyclase: significance of heme in regulating enzymatic activity and the role of the enzyme in platelet aggregation].
    Severina IS.
    Biokhimiia; 1994 Mar; 59(3):325-39. PubMed ID: 7910045
    [Abstract] [Full Text] [Related]

  • 10. [Nitric oxide. The role of guanylate cyclase in its physiological effects].
    Severina IS.
    Vopr Med Khim; 2002 Mar; 48(1):4-30. PubMed ID: 12068497
    [Abstract] [Full Text] [Related]

  • 11. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R.
    Cardiovasc Res; 2006 Jul 15; 71(2):393-401. PubMed ID: 16713591
    [Abstract] [Full Text] [Related]

  • 12. Benzodifuroxan as an NO-dependent activator of soluble guanylate cyclase and a novel highly effective inhibitor of platelet aggregation.
    Bussygina OG, Pyatakova NV, Khropov YV, Ovchinnikov IV, Makhova NN, Severina IS.
    Biochemistry (Mosc); 2000 Apr 15; 65(4):457-62. PubMed ID: 10810184
    [Abstract] [Full Text] [Related]

  • 13. [The soluble form of guanylate cyclase in the molecular mechanism of the physiological effects of nitric oxide and in regulating platelet aggregation].
    Severina IS.
    Biull Eksp Biol Med; 1995 Mar 15; 119(3):230-5. PubMed ID: 7795182
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Inhibition of human platelet aggregation by nitric oxide donor drugs: relative contribution of cGMP-independent mechanisms.
    Sogo N, Magid KS, Shaw CA, Webb DJ, Megson IL.
    Biochem Biophys Res Commun; 2000 Dec 20; 279(2):412-9. PubMed ID: 11118301
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of the effects of SIN-1, sodium nitroprusside and nitrate derivatives on the inhibition of blood platelet aggregation and activation of soluble platelet guanylate-cyclase].
    Karrenbrock B, Grewe R, Loeschke K, Gerzer R.
    Pathol Biol (Paris); 1987 Feb 20; 35(2 Pt 2):251-4. PubMed ID: 2882462
    [Abstract] [Full Text] [Related]

  • 19. Increase in reactivity of human platelet guanylate cyclase during aggregation potentiates the disaggregating capacity of sodium nitroprusside.
    Chirkov YY, Belushkina NN, Tyshchuk IA, Severina IS, Horowitz JD.
    Clin Exp Pharmacol Physiol; 1991 Jul 20; 18(7):517-24. PubMed ID: 1680588
    [Abstract] [Full Text] [Related]

  • 20. [Effect of N-(6-aminohexyl)-5-chloronaphthalene-1-sulfamide (W-7) and its analogs on the activity of soluble guanylate cyclase and on human platelet aggregation].
    Severina IS, Shirkov IuIu, Belushkina NN, Tyshchuk IA, Kulagin SV, Khropov IuV.
    Biokhimiia; 1990 Sep 20; 55(9):1717-24. PubMed ID: 1981851
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.